Evidence map›Paper›PMID 31673306›Full record

SynthesisMolecular autism2019

A meta-analysis of two high-risk prospective cohort studies reveals autism-specific transcriptional changes to chromatin, autoimmune, and environmental response genes in umbilical cord blood.

Charles E Mordaunt, Bo Y Park, Kelly M Bakulski, Jason I Feinberg, Lisa A Croen, Christine Ladd-Acosta, Craig J Newschaffer, Heather E Volk, Sally Ozonoff, Irva Hertz-Picciotto and 3 more

Open access · goldAbstract readMeta-Analysis
In one paragraph

Synthesis in Molecular autism, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it, 33 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Prenatal Interferon-Alpha Exposure Induces Autism-Like Neurobehavioral and Neurochemical Alterations in Male Offspring.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Light and sex modifybioRxiv : the preprint server for biology · 2025
    Article
  9. Exposure to heavy metalsmedRxiv : the preprint server for health sciences · 2023
    Article
  10. Review
  11. Article
  12. Gene×environment interactions in autism spectrum disorders.Current topics in developmental biology · 2023
    Review
  13. X Chromosome Inactivation Timing is Not eFrontiers in genetics · 2022
    Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 8 institutions in 1 country.

Charles E Mordaunt *1Department of Medical Microbiology and Immunology, Genome Center, and MIND Institute, University of California, Davis, CA USA.
Bo Y Park *2Department of Public Health, California State University, Fullerton, CA USA.
Kelly M Bakulski3Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, MI USA.
Jason I Feinberg4Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD USA.
Lisa A Croen5Division of Research and Autism Research Program, Kaiser Permanente Northern California, Oakland, CA USA.
Christine Ladd-Acosta4Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD USA.
Craig J Newschaffer6Department of Biobehavioral Health, College of Health and Human Development, Pennsylvania State University, University Park, PA USA.
Heather E Volk4Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD USA.
Sally Ozonoff7Psychiatry and Behavioral Sciences and MIND Institute, University of California, Davis, CA USA.
Irva Hertz-Picciotto8Department of Public Health Sciences and MIND Institute, University of California, Davis, CA USA.
Janine M LaSalle *1Department of Medical Microbiology and Immunology, Genome Center, and MIND Institute, University of California, Davis, CA USA.ORCID 0000-0002-3480-2031
Rebecca J Schmidt *8Department of Public Health Sciences and MIND Institute, University of California, Davis, CA USA.
M Daniele Fallin *4Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD USA.
Johns Hopkins University · USDepartment of Public Health · USUniversity of California Davis Medical Center · USCalifornia State University, Fullerton · USKaiser Permanente · USPennsylvania State University · USUniversity of California, Davis · USUniversity of Michigan · US

Funding

UC Davis Environmental Health Sciences Core CenterP30ES023513 · NIEHS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI Ameer Taha · 2015 to 2026
$26.0M
UC Davis Center for Children's Environmental Health (CCEH)P01ES011269 · NIEHS · UNIVERSITY OF CALIFORNIA DAVIS · PI VAN DE WATER, JUDY A. · 2001 to 2018
$12.5M
Building Interdisciplinary Research Careers in Womens Health at UC Davis - Administrative SupplementK12HD051958 · NICHD · UNIVERSITY OF CALIFORNIA DAVIS · PI LANE, NANCY E · 2005 to 2023
$9.6M
Autism Risk, Prenatal Environmental Exposures, and Pathophysiologic MarkersR01ES020392 · NIEHS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI HERTZ-PICCIOTTO, IRVA, OZONOFF, SALLY · 2011 to 2015
$9.0M
Environment, The Perinatal Epigenome, and Risk for Autism and Related DisordersR01ES017646 · NIEHS · JOHNS HOPKINS UNIVERSITY · PI FALLIN, M DANIELE, FEINBERG, ANDREW P. · 2009 to 2013
$8.7M
Rodent Behavior CoreU54HD079125 · NICHD · UNIVERSITY OF CALIFORNIA AT DAVIS · PI HERTZ-PICCIOTTO, IRVA · 2013 to 2019
$8.5M
PCB Epigenomic Brain & Behavior Lasting Effects Study (PEBBLES)R01ES029213 · NIEHS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI Janine M LaSalle, Pamela J Lein · 2018 to 2026
$6.5M
Revisiting ReCHARGE: ECHO Follow up on Middle Childhood and AdolescenceUG3OD023365 · OD · UNIVERSITY OF CALIFORNIA AT DAVIS · PI BENNETT, DEBORAH HALL, HERTZ-PICCIOTTO, IRVA · 2016 to 2024
$6.4M
Racial inequalities in health throughout adulthood: The cumulative impact of neighborhood chemical and non-chemical stressors on epigenomic pathwaysR01MD013299 · NIMHD · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI HICKEN, MARGARET TAKAKO · 2018 to 2022
$3.7M
Environmental Influence on Infant Microbiome Development and ASD SymptomsR01ES028089 · NIEHS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI HERTZ-PICCIOTTO, IRVA, MILLS, DAVID ANDREW · 2016 to 2020
$3.6M
Prenatal exposure to metals and risk for Autism Spectrum Disorder in MARBLES and EARLIR01ES025531 · NIEHS · JOHNS HOPKINS UNIVERSITY · PI VOLK, HEATHER E · 2016 to 2020
$3.2M
Folic Acid Prevention Pathways for ASD in High Risk FamiliesR01ES025574 · NIEHS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI SCHMIDT, REBECCA JEAN · 2015 to 2019
$3.1M
NIA NIH HHS R01 AG055406NICHD NIH HHS K12 HD051958NICHD NIH HHS U54 HD079125NIEHS NIH HHS P01 ES011269NIEHS NIH HHS P30 ES023513NIEHS NIH HHS R01 ES017646NIEHS NIH HHS R01 ES020392NIEHS NIH HHS R01 ES023780NIEHS NIH HHS R01 ES025531NIEHS NIH HHS R01 ES025574NIEHS NIH HHS R01 ES028089NIEHS NIH HHS R01 ES029213NIEHS NIH HHS R24 ES028533NIH HHS UG3 OD023365NIMHD NIH HHS R01 MD013299
6 · The paper itself

Abstract

Background: Autism spectrum disorder (ASD) is a neurodevelopmental disorder that affects more than 1% of children in the USA. ASD risk is thought to arise from both genetic and environmental factors, with the perinatal period as a critical window. Understanding early transcriptional changes in ASD would assist in clarifying disease pathogenesis and identifying biomarkers. However, little is known about umbilical cord blood gene expression profiles in babies later diagnosed with ASD compared to non-typically developing and non-ASD (Non-TD) or typically developing (TD) children. Methods: Genome-wide transcript levels were measured by Affymetrix Human Gene 2.0 array in RNA from cord blood samples from both the Markers of Autism Risk in Babies-Learning Early Signs (MARBLES) and the Early Autism Risk Longitudinal Investigation (EARLI) high-risk pregnancy cohorts that enroll younger siblings of a child previously diagnosed with ASD. Younger siblings were diagnosed based on assessments at 36 months, and 59 ASD, 92 Non-TD, and 120 TD subjects were included. Using both differential expression analysis and weighted gene correlation network analysis, gene expression between ASD and TD, and between Non-TD and TD, was compared within each study and via meta-analysis. Results: While cord blood gene expression differences comparing either ASD or Non-TD to TD did not reach genome-wide significance, 172 genes were nominally differentially expressed between ASD and TD cord blood (log Limitations: ASD-associated gene expression differences identified in this study are subtle, as cord blood is not the main affected tissue, it is composed of many cell types, and ASD is a heterogeneous disorder. Conclusions: This is the first study to identify gene expression differences in cord blood specific to ASD through a meta-analysis across two prospective pregnancy cohorts. The enriched gene pathways support involvement of environmental, immune, and epigenetic mechanisms in ASD etiology.

Indexed as

EnvironmentAdultAutistic DisorderAutoimmunityChildChromatinFemaleFetal BloodGene Expression RegulationGene Regulatory NetworksHumansMaleProspective StudiesRisk FactorsChromatinAutism spectrum disorderChromatinEnvironmentGene expressionMeta-analysisMicroarrayNeurodevelopmentPerinatalProspective studyUmbilical cord blood

Identifiers

PMID31673306
PMCPMC6814108
OpenAlexW2982175009

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.